SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
San Diego-based Illumina Inc. has acquired Myraqa, a regulatory and quality consulting firm specializing in in vitro diagnostics, particularly companion diagnostics, Illumina announced.
The city of San Diego plans to provide Illumina Inc. with tax rebates that should ensure the company keeps 300 middle-class manufacturing jobs in town, Mayor Kevin Faulconer announced.
San Diego-based Acadia Pharmaceuticals Inc. appointed Stephen Davis as executive vice president, chief financial officer and chief business officer, effective immediately, the company announced.
The board of directors of the Council of Community Clinics and its subsidiaries named Henry Tuttle as its new chief executive officer.
San Diego-based Otonomy Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for diseases and disorders of the inner and middle ear, has publicly filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of common stock.
San Diego-based Tocagen Inc. has raised $8.5 million of a planned $15.75 million investment round, according to a filing with the U.S. Securities and Exchange Commission.
The San Diego Business Journal is accepting nominations for 2014 Healthcare Champions, which honors individuals within the San Diego community who have demonstrated exceptional leadership, innovation and performance in the health care industry.
Hera Therapeutics Inc., a biotech startup operating in the Janssen Labs incubator, has raised $1.1 million in equity financing from 14 investors, according to a July 9 filing with the U.S. Securities and Exchange Commission.
Scripps Health and SCAN Health Plans have entered into a co-branding agreement to explore and develop new products and services designed to serve the growing senior population, the organizations announced.
San Diego-based bioTheranostics Inc., a provider of genomic cancer diagnostic solutions, said it signed a contract with FedMed Inc., based in Maryland and one of the largest preferred provider organizations in the nation.
San Diego-based MabVax Therapeutics Inc., a privately held cancer immunotherapy company, and Telik Inc., a publicly traded clinical-stage oncology drug development company, have finalized their merger.
Peter Beetham has taken the CEO’s job at Cibus, the Mira Mesa-based biotech announced July 8.
Property was 93 percent occupied when it was sold.
Financing could help fund global marketing.
Move comes after one year of being a public company.